Fresenius Kabi USA, LLC

Form 483 issued February 13, 2026 · Wilson, North Carolina

Inspection
Feb 3 – Feb 13, 2026
Observations
6
Pages
8
FEI number
3008887707

In short: On February 13, 2026, FDA issued a Form 483 with 6 observations to Fresenius Kabi USA, LLC in Wilson, North Carolina (FEI 3008887707) after an inspection that ran Feb 3 – Feb 13, 2026. The investigators were Ankur C. Patel, Karishma G. Gopaul and Yvins Dezan. Most observations concern production and facilities & equipment.

At a glance

Production and facilities & equipment account for 4 of 6 observations.

Production2
Facilities & equipment2
Quality system2

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    (Repeat) Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are…

  2. 02

    (Repeat) Equipment and utensils are not cleaned, maintained at appropriate intervals to prevent malfunctions contamination that…

  3. 03

    (Repeat) There is a failure to thoroughly review any unexplained discrepancy and the failure of a…

  4. 04

    The responsibilities and procedures applicable to the quality unit are not in…

2 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Fresenius Kabi USA, LLC?

FDA listed 6 observations on this Form 483, mostly about production, facilities & equipment and quality system. The opening words of each observation are shown on this page.

Who inspected Fresenius Kabi USA, LLC?

Ankur C. Patel, Karishma G. Gopaul and Yvins Dezan are named on this Form 483, for the inspection of Feb 3 – Feb 13, 2026. Each investigator has a profile showing what they cite most.

When was Fresenius Kabi USA, LLC inspected by FDA?

The inspection ran Feb 3 – Feb 13, 2026, and the Form 483 is dated February 13, 2026.

How do I get the full Form 483 for Fresenius Kabi USA, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free